How I manage patients with follicular lymphoma

被引：7
作者：
Casulo, Carla [1 ]
机构：
[1] Univ Rochester, Med Ctr, Wilmot Canc Inst, 601 Elmwood Ave Box 704, Rochester, NY 14618 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 186卷 / 04期
关键词：
follicular lymphoma; treatment; prognosis; NON-HODGKIN-LYMPHOMA; METABOLIC TUMOR VOLUME; OPEN-LABEL; PLUS RITUXIMAB; ADVANCED-STAGE; 1ST-LINE IMMUNOCHEMOTHERAPY; AUTOLOGOUS TRANSPLANTATION; RANDOMIZED-TRIAL; PROGNOSTIC VALUE; POOLED ANALYSIS;
D O I：
10.1111/bjh.16011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Recent advances in the treatment of follicular lymphoma (FL) have provided insight into molecular and biological influences on pathogenesis and prognosis. Additionally, numerous available treatment strategies for both newly diagnosed and relapsed disease require thoughtful consideration of patient selection to avoid the burden of overtreatment and toxicities. This review provides a broad overview on our approach to managing patients with low grade FL.
引用
收藏
页码：513 / 523
页数：11
相关论文
共 67 条
  • [1] [Anonymous], 2017, BLOOD S1
  • [2] [Anonymous], 2015, J CLIN ONCOL
  • [3] Rituximab versus a watch-and-wait approach in patients with advanced- stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial
    Ardeshna, Kirit M.
    Qian, Wendi
    Smith, Paul
    Braganca, Nivette
    Lowry, Lisa
    Patrick, Pip
    Warden, June
    Stevens, Lindsey
    Pocock, Christopher F. E.
    Miall, Fiona
    Cunningham, David
    Davies, John
    Jack, Andrew
    Stephens, Richard
    Walewski, Jan
    Ferhanoglu, Burhan
    Bradstock, Ken
    Linch, David C.
    [J]. LANCET ONCOLOGY, 2014, 15 (04) : 424 - 435
  • [4] Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial
    Ardeshna, KM
    Smith, P
    Norton, A
    Hancock, BW
    Hoskin, PJ
    MacLennan, KA
    Marcus, RE
    Jelliffe, A
    Hudson, GV
    Linch, DC
    [J]. LANCET, 2003, 362 (9383) : 516 - 522
  • [5] A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy
    Bachy, Emmanuel
    Maurer, Matthew J.
    Habermann, Thomas M.
    Gelas-Dore, Benedicte
    Maucort-Boulch, Delphine
    Estell, Jane A.
    Van den Neste, Eric
    Bouabdallah, Reda
    Gyan, Emmanuel
    Feldman, Andrew L.
    Bargay, Joan
    Delmer, Alain
    Slager, Susan L.
    da Silva, Maria Gomes
    Fitoussi, Olivier
    Belada, David
    Maisonneuve, Herve
    Intragumtornchai, Tanin
    Ansell, Stephen M.
    Lamy, Thierry
    Dartigues, Peggy
    Link, Brian K.
    Seymour, John F.
    Cerhan, James R.
    Salles, Gilles
    [J]. BLOOD, 2018, 132 (01) : 49 - 58
  • [6] Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial
    Bartlett, Nancy L.
    Costello, Brian A.
    LaPlant, Betsy R.
    Ansell, Stephen M.
    Kuruvilla, John G.
    Reeder, Craig B.
    Thye, Lim S.
    Anderson, Daniel M.
    Krysiak, Kilannin
    Ramirez, Cody
    Qi, Jing
    Siegel, Barry A.
    Griffith, Malachi
    Griffith, Obi L.
    Gomez, Felicia
    Fehniger, Todd A.
    [J]. BLOOD, 2018, 131 (02) : 182 - 190
  • [7] Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: A randomized study from the Groupe D'Etude des Lymphomes Folliculaires
    Brice, P
    Bastion, Y
    Lepage, E
    Brousse, N
    Haioun, C
    Moreau, P
    Straetmans, N
    Tilly, H
    Tabah, I
    SolalCeligny, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1110 - 1117
  • [8] Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study
    Burris, Howard A., III
    Flinn, Ian W.
    Patel, Manish R.
    Fenske, Timothy S.
    Deng, Changchun
    Brander, Danielle M.
    Gutierrez, Martin
    Essell, James H.
    Kuhn, John G.
    Miskin, Hari P.
    Sportelli, Peter
    Weiss, Michael S.
    Vakkalanka, Swaroop
    Savona, Michael R.
    O'Connor, Owen A.
    [J]. LANCET ONCOLOGY, 2018, 19 (04) : 486 - 496
  • [9] The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
    Campo, Elias
    Swerdlow, Steven H.
    Harris, Nancy L.
    Pileri, Stefano
    Stein, Harald
    Jaffe, Elaine S.
    [J]. BLOOD, 2011, 117 (19) : 5019 - 5032
  • [10] Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study
    Casulo, C.
    Day, B.
    Dawson, K. L.
    Zhou, X.
    Flowers, C. R.
    Farber, C. M.
    Hainsworth, J. D.
    Cerhan, J. R.
    Link, B. K.
    Zelenetz, A. D.
    Friedberg, J. W.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (11) : 2311 - 2317
1234567